Skip to main content.


You are impacting the future of cancer research. 

100% of funds raised through MD Anderson's Boot Walk to End Cancer support innovative research and new treatment standards that impact patients and families across the world. 
As the nation's No. 1 hospital for cancer care, we lead the nation in patient enrollment in clinical trials of new cancer therapies. 
In 2023, the FDA approved 43 new cancer drugs for public, clinical use. MD Anderson contributed to the development of 25 of those - nearly 60%. 

Since 2016, Boot Walk participants have raised more than $12.4 million to support critical research and patient programs at MD Anderson, including:

Thank you to our 2023 Top 100 Fundraisers!